Elon Musk’s Brain-chip Startup Aims for Scalability with New Transdural Procedure

Neuralink has successfully performed its first transdural brain implant surgery, a procedure that implants electrodes through the dura mater without cutting or removing it. The operation took place in May 2026 at Toronto Western Hospital as part of a clinical trial, marking a major technical milestone for the company’s goal of scalable, less invasive brain-computer interfaces (BCIs).

In a newly released video, Neuralink revealed that it has redesigned its insertion needle to penetrate the dura—the brain’s outer membrane—without the need for dura removal, which was required in previous human trials. This approach aims to reduce surgical trauma, simplify the procedure, and facilitate automation, potentially enabling broader application.

The surgery involved implanting electrode threads thinner than a human hair through the dura, which can be over ten times thicker than the electrodes. To navigate the moving brain and avoid blood vessels, Neuralink employed advanced imaging techniques, including indocyanine green (ICG) video angiography for blood flow visualization and optical coherence tomography (OCT) for measuring the distance to the brain surface. These innovations help to ensure precise and safe electrode placement.

Neuralink states that eliminating the dura removal step makes the surgery safer and more repeatable, which could be essential for scaling the technology to larger populations. The participant reportedly began controlling a cursor with their thoughts within an hour of the procedure, with recovery progressing as expected, according to Neuralink.

Implications for Safer, Scalable Brain Implants

This development could significantly impact the future of brain-computer interfaces by making surgical procedures less invasive and more repeatable. If Neuralink’s transdural approach proves successful at larger scales, it could accelerate the adoption of BCIs for medical and potentially consumer applications.

Reducing surgical trauma and automating procedures are critical steps toward making brain implants more accessible and safer, addressing longstanding challenges in the field. The ability to implant electrodes without dura removal may also lower risks associated with blood vessel damage and improve recovery times.

Advances in Neural Implant Surgery Techniques

Neuralink’s move to perform transdural implantation builds on prior efforts to develop minimally invasive BCI procedures. Previously, the company’s human trials involved removing part of the dura to insert electrodes, a delicate and invasive step. The new technique leverages innovations in imaging and needle design, inspired by the need to scale brain implants for broader use.

Other companies, such as Meta, are exploring non-invasive approaches using AI and advanced imaging to decode brain signals without surgery. However, Neuralink’s current focus remains on invasive methods that provide higher signal quality, essential for precise control and decoding of neural activity. The recent breakthrough aligns with the broader trend of refining surgical methods to balance safety, efficacy, and scalability in neural interfaces.

“‘Deleting the durectomy takes one of the most delicate manual steps out of the procedure, making it safer and more repeatable,’”

— Neuralink spokesperson

Uncertainties About Long-Term Outcomes and Scalability

It remains unclear how well the transdural technique will perform in larger patient populations over the long term. Details about the durability of the implants, potential complications, and whether this method can be widely adopted across different surgical settings are still emerging. Additionally, the regulatory pathway and approval process for scaling this procedure are yet to be clarified.

Next Steps for Validation and Broader Trials

Neuralink plans to continue clinical trials to assess the safety, efficacy, and scalability of the transdural method. Larger participant groups and longer follow-up periods will be necessary to confirm the technique’s benefits and identify any unforeseen risks. Regulatory submissions and approval processes will also be key milestones in bringing this technology closer to clinical and potential consumer use.

Key Questions

What is the significance of implanting electrodes through the dura without removing it?

This approach reduces surgical trauma, simplifies the procedure, and potentially makes brain implants safer and more scalable.

How does Neuralink ensure safety during the transdural procedure?

Neuralink uses advanced imaging techniques like ICG angiography and OCT to visualize blood flow and brain movement, helping avoid blood vessels and ensure precise electrode placement.

Is this technique ready for widespread clinical use?

Not yet. Neuralink is still in early trial phases, and further testing, larger studies, and regulatory approval are needed before it can be broadly adopted.

How does this compare to non-invasive brain-computer interfaces?

Invasive methods like Neuralink’s provide higher signal quality but require surgery, whereas non-invasive methods are safer but currently less precise. Both are still in development for practical applications.

What are the potential risks of transdural implantation?

While the technique aims to reduce risks, potential concerns include blood vessel damage, infection, and long-term stability of the implants, which are still being evaluated.

Source: Road to VR